Business

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance

COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 million. See company announcement no. 18/2025 for additional information about the PRV sale. After deduction of royalties to the National Institutes of Health and transaction costs, the net proceeds amount to DKK 810 million, which will be recognized as other operating income, an

articleBavarian Nordic A/sJuly 31, 20252/company/bavarian-nordic-as/news/bavarian-nordic-announces-closing-of-sale-of-priority-review-voucher-and-upgrades-its-2025-financial-guidance
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance

About this update from Bavarian Nordic A/s

[{"type":"image","alt":"Bavarian Nordic A/S","displaySize":"","headline":null,"caption":"Bavarian Nordic A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":224,"height":118,"url":"https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X7d037B4FI93H1mEWMcPsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0","width":224,"height":118}},"lazy":false},{"type":"text","content":"COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 million.","length":228,"tagName":"p"},{"type":"text","content":"See company announcement no. 18/2025 for additional information about the PRV sale.","length":83,"tagName":"p"},{"type":"text","content":"After deduction of royalties to the National Institutes of Health and transaction costs, the net proceeds amount to DKK 810 million, which will be recognized as other operating income, and will therefore not impact the Company’s revenue expectations for 2025. Similarly, the guided EBITDA margin of 26-30% for the regular business remains unchanged. However, when including the extraordinary income from the sale of the PRV, the total EBITDA margin is expected to be in the range of 40-42%.","length":490,"tagName":"p"},{"type":"text","content":"Breakdown of financial guidance for 2025, including upgrade:","length":60,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:217.4px;border-bottom:solid black 1pt;text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"DKK million","length":11,"tagName":"p","attribs":{}}]},{"style":"width:103.94px;border-bottom:solid black 1pt;text-align:right;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"FY 2025 guidance","length":16,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:217.4px;text-align:left;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Revenue","length":7,"tagName":"p","attribs":{}}]},{"style":"width:103.94px;text-align:right;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"5,700 – 6,700","length":...

More updates from Bavarian Nordic A/s

Bavarian NordicEBITDA marginNational Institutes of Healthoperating incomecompany announcementForward-looking statementsPRV